Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors

Case report: Complete remission of bone metastasis from renal cell carcinoma in histopathological examination after treatment with immune checkpoint inhibitors

Recently, the prognosis of metastatic renal cell carcinoma (mRCC) has improved owing to the development of immunotherapy using immune checkpoint inhibitors (ICIs). However, there have been few studies on the therapeutic effect of ICIs in bone metastases from renal cell carcinoma (RCC). We report a c...

Full description

Bibliographic Details
Main Authors: Yohei Asano, Norio Yamamoto, Katsuhiro Hayashi, Akihiko Takeuchi, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Yuta Taniguchi, Sei Morinaga, Takashi Horimoto, Masaharu Nakai, Yoshifumi Kadono, Takayuki Nojima, Hiroyuki Tsuchiya
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Immunology
Subjects:
renal cell carcinoma (RCC)
immune checkpoint inhibitor (ICI)
nivolumab
bone metastasis (BM)
pathological fracture
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.980456/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.980456/full

Similar Items